These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14993928)

  • 1. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes.
    Linderson Y; Eberhard D; Malin S; Johansson A; Busslinger M; Pettersson S
    EMBO Rep; 2004 Mar; 5(3):291-6. PubMed ID: 14993928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
    Linderson Y; French NS; Neurath MF; Pettersson S
    Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
    Laurencikiene J; Deveikaite V; Severinson E
    J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
    O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
    J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family.
    Eberhard D; Jiménez G; Heavey B; Busslinger M
    EMBO J; 2000 May; 19(10):2292-303. PubMed ID: 10811620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a candidate regulatory element within the 5' flanking region of the mouse Igh locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A.
    Pawlitzky I; Angeles CV; Siegel AM; Stanton ML; Riblet R; Brodeur PH
    J Immunol; 2006 Jun; 176(11):6839-51. PubMed ID: 16709844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
    Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
    Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins.
    Michaelson JS; Singh M; Snapper CM; Sha WC; Baltimore D; Birshtein BK
    J Immunol; 1996 Apr; 156(8):2828-39. PubMed ID: 8609402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSAP can repress enhancer activity by targeting PU.1 function.
    Maitra S; Atchison M
    Mol Cell Biol; 2000 Mar; 20(6):1911-22. PubMed ID: 10688639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
    Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
    EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    Sepulveda MA; Emelyanov AV; Birshtein BK
    J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal expression of a V(H) promoter-Cmu transgene linked to the IgH HS1,2 enhancer.
    Andersson T; Furebring C; Borrebaeck CA; Pettersson S
    Mol Immunol; 1999 Jan; 36(1):19-29. PubMed ID: 10369417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.
    Singh M; Birshtein BK
    Mol Cell Biol; 1993 Jun; 13(6):3611-22. PubMed ID: 8497273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5.
    Andersson T; Neurath MF; Grant PA; Pettersson S
    Eur J Immunol; 1996 Oct; 26(10):2499-507. PubMed ID: 8898966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
    Rao E; Dang W; Tian G; Sen R
    J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.